There is 1 paper on lean body mass loss in aging research: none in people yet, 1 review.
1 paper studies it17 more mention it2 findings
Interventions
2Tirzepatide
upin humans1
1 study
Tirzepatide
upin humans1
Tirzepatide increases lean body mass loss in humans (compared with semaglutide in routine care).
“tirzepatide exhibits greater absolute LBM reduction than semaglutide in routine care”
Reviewcompared with semaglutide in routine care
International Health Sciences Review
Incretin therapy
upin humans1+25% weight lost is lean mass
1 study
Incretin therapy
upin humans1+25% weight lost is lean mass
Incretin therapy induces lean body mass loss in humans during weight loss (approximately 25% of weight lost is lean mass).
“Clinical trials and real-world EHR phenotyping confirm that these therapies induce weight loss characterized by a consistent partitioning ratio—approximately 75% fat and 25% lean mass loss.”
Reviewduring weight loss
International Health Sciences Review
Latest
9 papers in 12 monthsInternational Health Sciences Review
Comparative incidence of sarcopenia across distinct GLP-1 receptor agonists in non-diabetic populations
ReviewGLP-1 receptor agonists
Research Square
Obesity, insulin resistance, and type 2 diabetes as determinants of bone mineral density in pre- and postmenopausal women: A systematic review
Preprint: systematic review of observational studiesBones and joints
Journal of Cachexia, Sarcopenia and Muscle
Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review
ReviewInterventions
Journal of Clinical Medicine
Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss
ReviewInterventions